Royal Gold [RGLD] vs Newmont [NEM] Detailed Stock Comparison
Royal Gold
NASDAQ
Loading...
Newmont
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Royal Gold wins in 6 metrics, Newmont wins in 14 metrics, with 0 ties. Newmont appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Royal Gold | Newmont | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 25.14 | 12.21 | Newmont |
| Price-to-Book Ratio | 4.34 | 2.31 | Newmont |
| Debt-to-Equity Ratio | 0.26 | 23.56 | Royal Gold |
| PEG Ratio | 0.40 | 0.08 | Newmont |
| EV/EBITDA | 21.49 | 6.87 | Newmont |
| Profit Margin (TTM) | 42.48% | 30.50% | Royal Gold |
| Operating Margin (TTM) | 50.53% | 45.46% | Royal Gold |
| EBITDA Margin (TTM) | 50.53% | 45.46% | Royal Gold |
| Return on Equity | 10.99% | 20.29% | Newmont |
| Return on Assets (TTM) | 7.44% | 9.07% | Newmont |
| Free Cash Flow (TTM) | $426.94M | $2.96B | Newmont |
| Dividend Yield | 1.20% | 1.29% | Newmont |
| 1-Year Return | 18.11% | 29.48% | Newmont |
| Price-to-Sales Ratio (TTM) | 17.49 | 3.60 | Newmont |
| Enterprise Value | $11.12B | $75.14B | Newmont |
| EV/Revenue Ratio | 17.23 | 3.65 | Newmont |
| Gross Profit Margin (TTM) | 72.56% | 50.71% | Royal Gold |
| Revenue per Share (TTM) | $10 | $18 | Newmont |
| Earnings per Share (Diluted) | $6.82 | $5.52 | Royal Gold |
| Beta (Stock Volatility) | 0.65 | 0.32 | Newmont |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Royal Gold vs Newmont Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Royal Gold | -2.82% | -3.27% | 5.86% | -3.69% | 11.71% | 23.91% |
| Newmont | -2.35% | -2.25% | 12.56% | 32.30% | 42.12% | 75.61% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Royal Gold | 18.11% | 73.19% | 23.09% | 240.64% | 234.83% | 629.27% |
| Newmont | 29.48% | 55.90% | 1.00% | 292.43% | 12.39% | 71.98% |
Performance & Financial Health Analysis: Royal Gold vs Newmont
| Metric | RGLD | NEM |
|---|---|---|
| Market Information | ||
| Market Cap | $11.29B | $74.01B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 948,270 | 7,987,180 |
| 90 Day Avg. Volume | 1,025,590 | 11,264,163 |
| Last Close | $166.71 | $67.38 |
| 52 Week Range | $130.67 - $191.78 | $36.86 - $70.29 |
| % from 52W High | -13.07% | -4.14% |
| All-Time High | $191.78 (Apr 21, 2025) | $86.37 (Apr 18, 2022) |
| % from All-Time High | -13.07% | -21.99% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.06% | 0.21% |
| Quarterly Earnings Growth | 0.14% | 1.42% |
| Financial Health | ||
| Profit Margin (TTM) | 0.42% | 0.31% |
| Operating Margin (TTM) | 0.51% | 0.45% |
| Return on Equity (TTM) | 0.11% | 0.20% |
| Debt to Equity (MRQ) | 0.26 | 23.56 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $39.48 | $29.17 |
| Cash per Share (MRQ) | $2.19 | $6.06 |
| Operating Cash Flow (TTM) | $461.87M | $8.57B |
| Levered Free Cash Flow (TTM) | $-594,125 | $9.16B |
| Dividends | ||
| Last 12-Month Dividend Yield | 1.20% | 1.29% |
| Last 12-Month Dividend | $2.15 | $0.75 |
Valuation & Enterprise Metrics Analysis: Royal Gold vs Newmont
| Metric | RGLD | NEM |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 25.14 | 12.21 |
| Forward P/E | 26.75 | 17.59 |
| PEG Ratio | 0.40 | 0.08 |
| Price to Sales (TTM) | 17.49 | 3.60 |
| Price to Book (MRQ) | 4.34 | 2.31 |
| Market Capitalization | ||
| Market Capitalization | $11.29B | $74.01B |
| Enterprise Value | $11.12B | $75.14B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 17.23 | 3.65 |
| Enterprise to EBITDA | 21.49 | 6.87 |
| Risk & Other Metrics | ||
| Beta | 0.65 | 0.32 |
| Book Value per Share (MRQ) | $39.48 | $29.17 |
Financial Statements Comparison: Royal Gold vs Newmont
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | RGLD | NEM |
|---|---|---|
| Revenue/Sales | $193.44M | $5.01B |
| Cost of Goods Sold | $59.26M | $2.70B |
| Gross Profit | $134.17M | $2.31B |
| Research & Development | N/A | $43.00M |
| Operating Income (EBIT) | $123.11M | $2.02B |
| EBITDA | $158.16M | $2.64B |
| Pre-Tax Income | $123.97M | $2.47B |
| Income Tax | $10.39M | $647.00M |
| Net Income (Profit) | $113.58M | $1.90B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | RGLD | NEM |
|---|---|---|
| Cash & Equivalents | $240.76M | $4.70B |
| Total Current Assets | $316.50M | $10.74B |
| Total Current Liabilities | $66.77M | $5.43B |
| Long-Term Debt | N/A | $7.88B |
| Total Shareholders Equity | $3.22B | $31.43B |
| Retained Earnings | $973.85M | $153.00M |
| Property, Plant & Equipment | N/A | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | RGLD | NEM |
|---|---|---|
| Operating Cash Flow | $143.82M | $2.62B |
| Capital Expenditures | $-58.25M | $858.00M |
| Free Cash Flow | $78.12M | $1.21B |
| Debt Repayment | $0 | $-1.01B |
| Common Stock Repurchase | $-3.01M | $-348.00M |
Short Interest & Institutional Ownership Analysis
| Metric | RGLD | NEM |
|---|---|---|
| Shares Short | 2.24M | 19.36M |
| Short Ratio | 2.36 | 1.56 |
| Short % of Float | 0.05% | 0.02% |
| Average Daily Volume (10 Day) | 948,270 | 7,987,180 |
| Average Daily Volume (90 Day) | 1,025,590 | 11,264,163 |
| Shares Outstanding | 65.69M | 1.13B |
| Float Shares | 65.29M | 1.10B |
| % Held by Insiders | 0.00% | 0.00% |
| % Held by Institutions | 0.90% | 0.80% |
Dividend Analysis & Yield Comparison: Royal Gold vs Newmont
| Metric | RGLD | NEM |
|---|---|---|
| Last 12-Month Dividend | $2.15 | $0.75 |
| Last 12-Month Dividend Yield | 1.20% | 1.29% |
| 3-Year Avg Annual Dividend | $1.72 | $1.18 |
| 3-Year Avg Dividend Yield | 0.31% | 0.84% |
| 3-Year Total Dividends | $5.17 | $3.55 |
| Ex-Dividend Date | Jul 03, 2025 | Mar 04, 2025 |